Cargando…

Optimal cut points of plasma and urine neutrophil gelatinase-associated lipocalin for the prediction of acute kidney injury among critically ill adults: retrospective determination and clinical validation of a prospective multicentre study

OBJECTIVES: To determine the optimal threshold of blood and urine neutrophil gelatinase-associated lipocalin (NGAL) to predict moderate to severe acute kidney injury (AKI) and persistent moderate to severe AKI lasting at least 48 consecutive hours, as defined by an adjudication panel. METHODS: A mul...

Descripción completa

Detalles Bibliográficos
Autores principales: Tecson, Kristen M, Erhardtsen, Elisabeth, Eriksen, Peter M, Gaber, A Osama, Germain, Michael, Golestaneh, Ladan, Lavoria, Maria de los Angeles, Moore, Linda W, McCullough, Peter A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5726065/
https://www.ncbi.nlm.nih.gov/pubmed/28698338
http://dx.doi.org/10.1136/bmjopen-2017-016028
_version_ 1783285663628525568
author Tecson, Kristen M
Erhardtsen, Elisabeth
Eriksen, Peter M
Gaber, A Osama
Germain, Michael
Golestaneh, Ladan
Lavoria, Maria de los Angeles
Moore, Linda W
McCullough, Peter A
author_facet Tecson, Kristen M
Erhardtsen, Elisabeth
Eriksen, Peter M
Gaber, A Osama
Germain, Michael
Golestaneh, Ladan
Lavoria, Maria de los Angeles
Moore, Linda W
McCullough, Peter A
author_sort Tecson, Kristen M
collection PubMed
description OBJECTIVES: To determine the optimal threshold of blood and urine neutrophil gelatinase-associated lipocalin (NGAL) to predict moderate to severe acute kidney injury (AKI) and persistent moderate to severe AKI lasting at least 48 consecutive hours, as defined by an adjudication panel. METHODS: A multicentre prospective observational study enrolled intensive care unit (ICU) patients and recorded daily ethylenediaminetetraacetic acid (EDTA) plasma, heparin plasma and urine NGAL. We used natural log-transformed NGAL in a logistic regression model to predict stage 2/3 AKI (defined by Kidney Disease International Global Organization). We performed the same analysis using the NGAL value at the start of persistent stage 2/3 AKI. RESULTS: Of 245 subjects, 33 (13.5%) developed stage 2/3 AKI and 25 (10.2%) developed persistent stage 2/3 AKI. Predicting stage 2/3 AKI revealed the optimal NGAL cutoffs in EDTA plasma (142.0 ng/mL), heparin plasma (148.3 ng/mL) and urine (78.0 ng/mL) and yielded the following decision statistics: sensitivity (SN)=78.8%, specificity (SP)=73.0%, positive predictive value (PPV)=31.3%, negative predictive value (NPV)=95.7%, diagnostic accuracy (DA)=73.8% (EDTA plasma); SN=72.7%, SP=73.8%, PPV=30.4%, NPV=94.5%, DA=73.7% (heparin plasma); SN=69.7%, SP=76.8%, PPV=32.9%, NPV=94%, DA=75.8% (urine). The optimal NGAL cutoffs to predict persistent stage 2/3 AKI were similar: 148.3 ng/mL (EDTA plasma), 169.6 ng/mL (heparin plasma) and 79.0 ng/mL (urine) yielding: SN=84.0%, SP=73.5%, PPV=26.6%, NPV=97.6, DA=74.6% (EDTA plasma), SN=84%, SP=76.1%, PPV=26.8%, NPV=96.5%, DA=76.1% (heparin plasma) and SN=75%, SP=75.8%, PPV=26.1, NPV=96.4%, DA=75.7% (urine). CONCLUSION: Blood and urine NGAL predicted stage 2/3 AKI, as well as persistent 2/3 AKI in the ICU with acceptable decision statistics using a single cut point in each type of specimen.
format Online
Article
Text
id pubmed-5726065
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-57260652017-12-19 Optimal cut points of plasma and urine neutrophil gelatinase-associated lipocalin for the prediction of acute kidney injury among critically ill adults: retrospective determination and clinical validation of a prospective multicentre study Tecson, Kristen M Erhardtsen, Elisabeth Eriksen, Peter M Gaber, A Osama Germain, Michael Golestaneh, Ladan Lavoria, Maria de los Angeles Moore, Linda W McCullough, Peter A BMJ Open Renal Medicine OBJECTIVES: To determine the optimal threshold of blood and urine neutrophil gelatinase-associated lipocalin (NGAL) to predict moderate to severe acute kidney injury (AKI) and persistent moderate to severe AKI lasting at least 48 consecutive hours, as defined by an adjudication panel. METHODS: A multicentre prospective observational study enrolled intensive care unit (ICU) patients and recorded daily ethylenediaminetetraacetic acid (EDTA) plasma, heparin plasma and urine NGAL. We used natural log-transformed NGAL in a logistic regression model to predict stage 2/3 AKI (defined by Kidney Disease International Global Organization). We performed the same analysis using the NGAL value at the start of persistent stage 2/3 AKI. RESULTS: Of 245 subjects, 33 (13.5%) developed stage 2/3 AKI and 25 (10.2%) developed persistent stage 2/3 AKI. Predicting stage 2/3 AKI revealed the optimal NGAL cutoffs in EDTA plasma (142.0 ng/mL), heparin plasma (148.3 ng/mL) and urine (78.0 ng/mL) and yielded the following decision statistics: sensitivity (SN)=78.8%, specificity (SP)=73.0%, positive predictive value (PPV)=31.3%, negative predictive value (NPV)=95.7%, diagnostic accuracy (DA)=73.8% (EDTA plasma); SN=72.7%, SP=73.8%, PPV=30.4%, NPV=94.5%, DA=73.7% (heparin plasma); SN=69.7%, SP=76.8%, PPV=32.9%, NPV=94%, DA=75.8% (urine). The optimal NGAL cutoffs to predict persistent stage 2/3 AKI were similar: 148.3 ng/mL (EDTA plasma), 169.6 ng/mL (heparin plasma) and 79.0 ng/mL (urine) yielding: SN=84.0%, SP=73.5%, PPV=26.6%, NPV=97.6, DA=74.6% (EDTA plasma), SN=84%, SP=76.1%, PPV=26.8%, NPV=96.5%, DA=76.1% (heparin plasma) and SN=75%, SP=75.8%, PPV=26.1, NPV=96.4%, DA=75.7% (urine). CONCLUSION: Blood and urine NGAL predicted stage 2/3 AKI, as well as persistent 2/3 AKI in the ICU with acceptable decision statistics using a single cut point in each type of specimen. BMJ Publishing Group 2017-07-10 /pmc/articles/PMC5726065/ /pubmed/28698338 http://dx.doi.org/10.1136/bmjopen-2017-016028 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Renal Medicine
Tecson, Kristen M
Erhardtsen, Elisabeth
Eriksen, Peter M
Gaber, A Osama
Germain, Michael
Golestaneh, Ladan
Lavoria, Maria de los Angeles
Moore, Linda W
McCullough, Peter A
Optimal cut points of plasma and urine neutrophil gelatinase-associated lipocalin for the prediction of acute kidney injury among critically ill adults: retrospective determination and clinical validation of a prospective multicentre study
title Optimal cut points of plasma and urine neutrophil gelatinase-associated lipocalin for the prediction of acute kidney injury among critically ill adults: retrospective determination and clinical validation of a prospective multicentre study
title_full Optimal cut points of plasma and urine neutrophil gelatinase-associated lipocalin for the prediction of acute kidney injury among critically ill adults: retrospective determination and clinical validation of a prospective multicentre study
title_fullStr Optimal cut points of plasma and urine neutrophil gelatinase-associated lipocalin for the prediction of acute kidney injury among critically ill adults: retrospective determination and clinical validation of a prospective multicentre study
title_full_unstemmed Optimal cut points of plasma and urine neutrophil gelatinase-associated lipocalin for the prediction of acute kidney injury among critically ill adults: retrospective determination and clinical validation of a prospective multicentre study
title_short Optimal cut points of plasma and urine neutrophil gelatinase-associated lipocalin for the prediction of acute kidney injury among critically ill adults: retrospective determination and clinical validation of a prospective multicentre study
title_sort optimal cut points of plasma and urine neutrophil gelatinase-associated lipocalin for the prediction of acute kidney injury among critically ill adults: retrospective determination and clinical validation of a prospective multicentre study
topic Renal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5726065/
https://www.ncbi.nlm.nih.gov/pubmed/28698338
http://dx.doi.org/10.1136/bmjopen-2017-016028
work_keys_str_mv AT tecsonkristenm optimalcutpointsofplasmaandurineneutrophilgelatinaseassociatedlipocalinforthepredictionofacutekidneyinjuryamongcriticallyilladultsretrospectivedeterminationandclinicalvalidationofaprospectivemulticentrestudy
AT erhardtsenelisabeth optimalcutpointsofplasmaandurineneutrophilgelatinaseassociatedlipocalinforthepredictionofacutekidneyinjuryamongcriticallyilladultsretrospectivedeterminationandclinicalvalidationofaprospectivemulticentrestudy
AT eriksenpeterm optimalcutpointsofplasmaandurineneutrophilgelatinaseassociatedlipocalinforthepredictionofacutekidneyinjuryamongcriticallyilladultsretrospectivedeterminationandclinicalvalidationofaprospectivemulticentrestudy
AT gaberaosama optimalcutpointsofplasmaandurineneutrophilgelatinaseassociatedlipocalinforthepredictionofacutekidneyinjuryamongcriticallyilladultsretrospectivedeterminationandclinicalvalidationofaprospectivemulticentrestudy
AT germainmichael optimalcutpointsofplasmaandurineneutrophilgelatinaseassociatedlipocalinforthepredictionofacutekidneyinjuryamongcriticallyilladultsretrospectivedeterminationandclinicalvalidationofaprospectivemulticentrestudy
AT golestanehladan optimalcutpointsofplasmaandurineneutrophilgelatinaseassociatedlipocalinforthepredictionofacutekidneyinjuryamongcriticallyilladultsretrospectivedeterminationandclinicalvalidationofaprospectivemulticentrestudy
AT lavoriamariadelosangeles optimalcutpointsofplasmaandurineneutrophilgelatinaseassociatedlipocalinforthepredictionofacutekidneyinjuryamongcriticallyilladultsretrospectivedeterminationandclinicalvalidationofaprospectivemulticentrestudy
AT moorelindaw optimalcutpointsofplasmaandurineneutrophilgelatinaseassociatedlipocalinforthepredictionofacutekidneyinjuryamongcriticallyilladultsretrospectivedeterminationandclinicalvalidationofaprospectivemulticentrestudy
AT mcculloughpetera optimalcutpointsofplasmaandurineneutrophilgelatinaseassociatedlipocalinforthepredictionofacutekidneyinjuryamongcriticallyilladultsretrospectivedeterminationandclinicalvalidationofaprospectivemulticentrestudy